United StatesCongress
hr 7630Bill

Childhood Cancer STAR Reauthorization Act of 2022

To maximize discovery, and accelerate development and availability, of promising childhood cancer treatments, and for other purposes.

Introduced on April 28, 2022

House
Senate
President